Celldex Therapeutics | CLDX - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 16.62B 840M 2025-12
Agenus USD 24.07M 2.77M 2025-03
Amgen USD 9.9B 340M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celldex Therapeutics USD 121K 769K 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Nektar Therapeutics USD 24.12M 635K 2024-09
Northwest Biotherapeutics USD 445K 39K 2023-12
Pfizer USD 17.58B 880M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12